Drug delivery to the posterior segment of the eye: biopharmaceutic and pharmacokinetic considerations

R Varela-Fernández, V Díaz-Tomé… - Pharmaceutics, 2020 - mdpi.com
The treatment of the posterior-segment ocular diseases, such as age-related eye diseases
(AMD) or diabetic retinopathy (DR), present a challenge for ophthalmologists due to the …

Pathogenesis of non-infectious uveitis elucidated by recent genetic findings

M Takeuchi, N Mizuki, S Ohno - Frontiers in immunology, 2021 - frontiersin.org
Uveitis is a generic term for inflammation of the uvea, which includes the iris, ciliary body,
and choroid. Prevalence of underlying non-infectious uveitis varies by race and region and …

Ocular manifestations of Behçet's disease: an update on diagnostic challenges and disease management

H Zając, A Turno-Kręcicka - Journal of Clinical Medicine, 2021 - mdpi.com
Behçet's disease is a systemic vasculitis that affects multiple organs. The most common
manifestations are oral and genital ulcerations and recurrent uveitis. Uveitis can be an initial …

The large Hellenic study of uveitis: diagnostic and therapeutic algorithms, complications, and final outcome

D Kalogeropoulos, I Asproudis… - The Asia-Pacific …, 2023 - journals.lww.com
Purpose: The purpose of this study is to present the diagnostic and therapeutic algorithms,
complications, and final outcome in the management of uveitic patients at a tertiary …

Current knowledge of biologics in treatment of noninfectious uveitis

S Gupta, K Shyamsundar, M Agrawal… - Journal of Ocular …, 2022 - liebertpub.com
The arena of uveitis deals with a number of entities, which can be infectious or immune
mediated. Noninfectious uveitis (NIU) has been managed with corticosteroids and …

Indications and effects of biological agents in the treatment of noninfectious uveitis

B Li, L Yang, F Bai, B Tong, X Liu - Immunotherapy, 2022 - Taylor & Francis
Noninfectious uveitis is a common blinding eye disease, and an autoimmune response is
involved in its pathogenesis. Biological agents have gradually been introduced into the …

Dupilumab induced ocular surface diseases: an analysis of FAERS database, literature review and disease-gene interaction networks

J Chen, H Li, H Zhang, Q ShenTu, S Wang… - Expert Opinion on …, 2025 - Taylor & Francis
Background Adverse events (AE) in dupilumab induced ocular surface diseases (DIOSD)
have raised concerns regarding its safety. The objective of this study was to evaluate DIOSD …

[HTML][HTML] Pattern of non-infectious uveitis and visual outcome in a tertiary care university-based hospital: A multidisciplinary approach

AH Eldesouky, MR Fadel, SA Husein… - The Egyptian …, 2023 - Elsevier
Aim of the work To study the pattern of non-infectious uveitis (NIU) in different systemic
autoimmune diseases and to determine the visual outcome and complications in relation to …

[HTML][HTML] Современные представления об офтальмологических проявлениях хронических миелопролиферативных новообразований

ЛК Мошетова, ЛБ Егорян… - Вестник Российской …, 2023 - cyberleninka.ru
Течение хронических миелопролиферативных новообразований (ХМПН), группы
системных гематологических заболеваний, может сопровождаться различными …

Intravitreal immunotherapy in non-infectious uveitis: an update

NK Menia, S Mohan, A Agarwal - Expert Review of Clinical …, 2023 - Taylor & Francis
Introduction In the past several years, there have been numerous advances in
pharmacotherapeutics for the management of uveitis and other ocular inflammatory …